These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21157331)

  • 21. An unusual cause of oesophageal variceal bleeding in a Chinese human immunodeficiency virus-infected patient.
    Hui YT; Lam WY; Lee MP; Lam TW; Li P
    Hong Kong Med J; 2013 Feb; 19(1):77-9. PubMed ID: 23378360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients.
    Vispo E; Cevik M; Rockstroh JK; Barreiro P; Nelson M; Scourfield A; Boesecke C; Wasmuth JC; Soriano V;
    Clin Infect Dis; 2013 Apr; 56(8):1117-22. PubMed ID: 23315321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.
    Parikh ND; Martel-Laferriere V; Kushner T; Childs K; Vachon ML; Dronamraju D; Taylor C; Fiel MI; Schiano T; Nelson M; Agarwal K; Dieterich DT
    J Infect Dis; 2014 Mar; 209(5):734-8. PubMed ID: 23911709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
    Vispo E; Maida I; Barreiro P; Moreno V; Soriano V
    HIV Clin Trials; 2008; 9(6):440-4. PubMed ID: 19203910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood.
    Scherpbier HJ; Terpstra V; Pajkrt D; Puthakanit T; Ananworanich J; Foster C; van den Bergh Weerman M; Deurloo EE; van der Valk M; Kuijpers TW; Koot BG
    Pediatr Infect Dis J; 2016 Aug; 35(8):e248-52. PubMed ID: 27167116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients.
    Mallet V; Blanchard P; Verkarre V; Vallet-Pichard A; Fontaine H; Lascoux-Combe C; Pol S
    AIDS; 2007 Jan; 21(2):187-92. PubMed ID: 17197809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe liver disease associated with prolonged exposure to antiretroviral drugs.
    Maida I; Núñez M; Ríos MJ; Martín-Carbonero L; Sotgiu G; Toro C; Rivas P; Barreiro P; Mura MS; Babudieri S; Garcia-Samaniego J; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):177-82. PubMed ID: 16688096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncirrhotic portal hypertension and didanosine: a re-analysis.
    Young J; Klein MB; Ledergerber B
    Clin Infect Dis; 2011 Jan; 52(1):154-5. PubMed ID: 21148537
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
    Vallet-Pichard A; Pol S
    J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.
    Schiano TD; Uriel A; Dieterich DT; Fiel MI
    Virchows Arch; 2011 Feb; 458(2):231-5. PubMed ID: 21057809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.
    Moore E; Beadsworth MB; Chaponda M; Mhango B; Faragher B; Njala J; Hofland HW; Davies J; Hart IJ; Beeching NJ; Zijlstra EE; van Oosterhout JJ
    J Infect; 2010 Jul; 61(2):155-63. PubMed ID: 20470823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.
    Yajima K; Uehira T; Otera H; Koizumi Y; Watanabe D; Kodama Y; Kuzushita N; Nishida Y; Mita E; Mano M; Shirasaka T
    J Infect Chemother; 2014 Sep; 20(9):582-5. PubMed ID: 25034388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
    Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
    Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].
    Schouten JN; Verheij J; Janssen HL
    Ned Tijdschr Geneeskd; 2010; 154():A1276. PubMed ID: 20456763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.